Related references
Note: Only part of the references are listed.Repurposing drugs in oncology: From candidate selection to clinical adoption
Pan Pantziarka et al.
SEMINARS IN CANCER BIOLOGY (2021)
Association of post-diagnostic use of cholera vaccine with survival outcome in breast cancer patients
Guoqiao Zheng et al.
BRITISH JOURNAL OF CANCER (2021)
Association of postoperative influenza vaccine on overall mortality in patients undergoing curative surgery for solid tumors
Mikail Gogenur et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors
Curtis R. Chong et al.
CLINICAL INFECTIOUS DISEASES (2020)
Repurposing the yellow fever vaccine for intratumoral immunotherapy
Maria Angela Aznar et al.
EMBO MOLECULAR MEDICINE (2020)
Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy
Siri Tahtinen et al.
CANCER RESEARCH (2020)
Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study
Melissa Bersanelli et al.
IMMUNOTHERAPY (2020)
Clinical and molecular insights into BCG immunotherapy for melanoma
M. Kremenovic et al.
JOURNAL OF INTERNAL MEDICINE (2020)
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer
Jenna H. Newman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Repurposing infectious disease vaccines for intratumoral immunotherapy
Ignacio Melero et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Attenuated measles vaccine strain have potent oncolytic activity against Iraqi patient derived breast cancer cell line
Sulaiman A. Abdullah et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2020)
Impact of flu vaccine on survival after immunotherapy for metastatic castration resistant prostate cancer (mCRPC): Analysis of Medicare claims data.
Russell Kent Pachynski et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in Glioblastoma
Kristen A. Batich et al.
CLINICAL CANCER RESEARCH (2020)
Evidence for a causal role by human papillomaviruses in prostate cancer - a systematic review
James S. Lawson et al.
INFECTIOUS AGENTS AND CANCER (2020)
Mycobacteria-Based Vaccines as Immunotherapy for Non-urological Cancers
Estela Noguera-Ortega et al.
CANCERS (2020)
Prophylactic HPV vaccination after conization: A systematic review and meta-analysis
M. Jentschke et al.
VACCINE (2020)
Efficacy of BCG vaccine and Mitomycin C for the treatment of ocular squamous cell carcinoma in bovines
Veena Podarala et al.
RESEARCH IN VETERINARY SCIENCE (2020)
Safety of Influenza Vaccine in Patients With Cancer Receiving Pembrolizumab
Jarrett J. Failing et al.
JCO ONCOLOGY PRACTICE (2020)
Measles virus in cancer therapy
Michael D. Muehlebach
CURRENT OPINION IN VIROLOGY (2020)
Intravesical Ty21a Vaccine Promotes Dendritic Cells and T Cell-Mediated Tumor Regression in the MB49 Bladder Cancer Model
Sonia Domingos-Pereira et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Turning the corner on therapeutic cancer vaccines
Robert E. Hollingsworth et al.
NPJ VACCINES (2019)
Could hepatitis B vaccine act as an adjuvant to lower risk and relapses of cancer?
Meric A. Altinoz et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2019)
Combination of Vaccine Strain Measles Virus and Nimotuzumab in the Treatment of Laryngeal Cancer
Nguyen Linh Toan et al.
ANTICANCER RESEARCH (2019)
Mycobacterium bovis BCG in metastatic melanoma therapy
Martha Lucia Ruiz Benitez et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2019)
Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade
Tala Shekarian et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Smallpox and BCG vaccination in childhood and cutaneous malignant melanoma in Danish adults followed from 18 to 49 years
Andreas Rieckmann et al.
VACCINE (2019)
Use of Combination Systemic-Intratumoral HPV Vaccine to Treat Cutaneous Basaloid Squamous Cell Carcinomas
Florence Brunet-Possenti et al.
JAMA DERMATOLOGY (2019)
Repurposing Food and Drug Administration-Approved Drugs to Promote Antitumor Immunity
Vidula V. Sukhatme et al.
CANCER JOURNAL (2019)
Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA) A Trial Protocol
Helen C. Stankiewicz Karita et al.
JAMA NETWORK OPEN (2019)
Yellow fever vaccine 17D administered to healthy women aged between 40 and 54 years halves breast cancer risk: an observational study
Giuseppe Mastrangelo et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2018)
Combination of Vaccine-Strain Measles and Mumps Viruses Enhances Oncolytic Activity against Human Solid Malignancies
Ho Anh Son et al.
CANCER INVESTIGATION (2018)
Cholera Vaccine Use Is Associated With a Reduced Risk of Death in Patients With Colorectal Cancer: A Population-Based Study
Jianguang Ji et al.
GASTROENTEROLOGY (2018)
Association between post-diagnostic use of cholera vaccine and risk of death in prostate cancer patients
Jianguang Ji et al.
NATURE COMMUNICATIONS (2018)
Combined Systemic and Intratumoral Administration of Human Papillomavirus Vaccine to Treat Multiple Cutaneous Basaloid Squamous Cell Carcinomas
Anna J. Nichols et al.
JAMA DERMATOLOGY (2018)
Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette-Guerin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma
Jessica Da Gama Duarte et al.
FRONTIERS IN IMMUNOLOGY (2018)
Phosphodiesterase-5 inhibition reduces postoperative metastatic disease by targeting surgery-induced myeloid derived suppressor cell-dependent inhibition of Natural Killer cell cytotoxicity
Lee-Hwa Tai et al.
ONCOIMMUNOLOGY (2018)
Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events
Heinz Laeubli et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Protective immunity elicited by measles vaccine exerts anti-tumor effects on measles virus hemagglutinin gene-modified cancer cells in a mouse model
Yuan Qi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence?
Yi Ji et al.
JOURNAL OF DERMATOLOGY (2018)
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study
Melissa Bersanelli et al.
IMMUNOTHERAPY (2018)
Trends in the global immuno-oncology landscape
Jun Tang et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
ReDO_DB: the repurposing drugs in oncology database
Pan Pantziarka et al.
ECANCERMEDICALSCIENCE (2018)
Bacillus Calmette Guerin (BCG) activates lymphocyte to promote autophagy and apoptosis of gastric cancer MGC-803 cell
Keyu Yao et al.
CELLULAR AND MOLECULAR BIOLOGY (2018)
Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer
Sonia Domingos-Pereira et al.
ONCOIMMUNOLOGY (2017)
BCG immune activation reduces growth and angiogenesis in an in vitro model of head and neck squamous cell carcinoma
Carolina Sanchez-Rodriguez et al.
VACCINE (2017)
Human Papillomavirus Vaccination and Keratinocyte Carcinomas
Jonathan E. Mayer
JAMA DERMATOLOGY (2017)
Association of Human Papillomavirus Vaccine With the Development of Keratinocyte Carcinomas
Anna J. Nichols et al.
JAMA DERMATOLOGY (2017)
Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells
Miyuki Tanaka et al.
CLINICAL CANCER RESEARCH (2017)
Surgical immune interventions for solid malignancies
Masha Zeltsman et al.
AMERICAN JOURNAL OF SURGERY (2016)
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity
Kalijn F. Bol et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Treatment of sarcoids in equids: 230 cases (2008–2013)
Maarten Haspeslagh et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2016)
Measles to the Rescue: A Review of Oncolytic Measles Virus
Sarah Aref et al.
VIRUSES-BASEL (2016)
Association Between β-Genus Human Papillomavirus and Cutaneous Squamous Cell Carcinoma in Immunocompetent Individuals-A Meta-analysis
Jad Chahoud et al.
JAMA DERMATOLOGY (2016)
Experimental Adaptation of Rotaviruses to Tumor Cell Lines
Carlos A. Guerrero et al.
PLOS ONE (2016)
Effective multiple oral administration of reverse genetics engineered infectious bursal disease virus in mice in the presence of neutralizing antibodies
Akos Hornyak et al.
JOURNAL OF GENE MEDICINE (2015)
Combination Radiofrequency Ablation and Local Injection of the Immunostimulant Bacillus Calmette-Guerin Induces Antitumor Immunity in the Lung and at a Distant VX2 Tumor in a Rabbit Model
Shinichi Hamamoto et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2015)
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
Duane A. Mitchell et al.
NATURE (2015)
Drug repurposing in oncology-patient and health systems opportunities
Francesco Bertolini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Cholera Toxin B: One Subunit with Many Pharmaceutical Applications
Keegan J. Baldauf et al.
TOXINS (2015)
Cholera-toxin suppresses carcinogenesis in a mouse model of inflammation-driven sporadic colon cancer
Michael Doulberis et al.
CARCINOGENESIS (2015)
Combination of vaccine-strain measles and mumps virus synergistically kills a wide range of human hematological cancer cells: Special focus on acute myeloid leukemia
Li Feng Zhang et al.
CANCER LETTERS (2014)
Tuberculosis and cancer on a BCG vaccination site: an instance of immunocompromised district
Ada Lo Schiavo et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2014)
Vulval cancer and HPV vaccination in recurrent disease
L. W. Gustafson et al.
CLINICAL CASE REPORTS (2014)
Preventing Postoperative Metastatic Disease by Inhibiting Surgery-Induced Dysfunction in Natural Killer Cells
Lee-Hwa Tai et al.
CANCER RESEARCH (2013)
Perioperative Influenza Vaccination Reduces Postoperative Metastatic Disease by Reversing Surgery-Induced Dysfunction in Natural Killer Cells
Lee-Hwa Tai et al.
CLINICAL CANCER RESEARCH (2013)
Spontaneous regression of metastatic melanoma after inoculation with tetanus-diphtheria-pertussis vaccine
T. Tran et al.
CURRENT ONCOLOGY (2013)
Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)?
Woo Dae Kang et al.
GYNECOLOGIC ONCOLOGY (2013)
Live attenuated measles virus vaccine induces apoptosis and promotes tumor regression in lung cancer
Danhua Zhao et al.
ONCOLOGY REPORTS (2013)
Preventing surgery-induced NK cell dysfunction and cancer metastases with influenza vaccination
Lee-Hwa Tai et al.
ONCOIMMUNOLOGY (2013)
Squamous cell carcinoma possibly originating from a granuloma following vaccination with Bacille Calmette-Guerin
Tomomi Fujisawa et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2013)
Tufted angioma arising at a site of BCG vaccination
Yue-Ping Zeng et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2013)
Biological Response Modifiers Influence Structure Function Relationship of Hematopoietic Stem and Stromal Cells in a Mouse Model of Leukemia
Kaustuv Basu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy
Daniel W. Fowler et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Lenalidomide-Induced Immunomodulation in Multiple Myeloma: Impact on Vaccines and Antitumor Responses
Kimberly Noonan et al.
CLINICAL CANCER RESEARCH (2012)
Prevention of Recurrent High-Grade Anal Neoplasia With Quadrivalent Human Papillomavirus Vaccination of Men Who Have Sex With Men: A Nonconcurrent Cohort Study
Kristin A. Swedish et al.
CLINICAL INFECTIOUS DISEASES (2012)
Attenuated Oncolytic Measles Virus Strains as Cancer Therapeutics
P. Msaouel et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
The yellow fever 17D vaccine and risk of malignant melanoma in the United States military
Meredith Hodges-Vazquez et al.
VACCINE (2012)
Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data
Tito Lopes
JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE (2012)
Chemotherapeutically Induced Cutaneous Tuberculosis after BCG Injection in a Patient with Pelvic Osteosarcoma
Giovanni Zoccali et al.
SURGICAL INFECTIONS (2012)
Enhancement of myeloma development mediated though myeloma cell-Th2 cell interactions after microbial antigen presentation by myeloma cells and DCs
F. Tian et al.
BLOOD CANCER JOURNAL (2012)
Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles
Mark S. Ferguson et al.
ADVANCES IN VIROLOGY (2012)
A Pilot Case-Cohort Study of Liver and Pancreatic Cancers in Poultry Workers
Martha Felini et al.
ANNALS OF EPIDEMIOLOGY (2011)
Supernatants from lymphocytes stimulated with Bacillus Calmette-Guerin can modify the antigenicity of tumours and stimulate allogeneic T-cell responses
W. M. Liu et al.
BRITISH JOURNAL OF CANCER (2011)
Internalization of Oncolytic Reovirus by Human Dendritic Cell Carriers Protects the Virus from Neutralization
Elizabeth J. Ilett et al.
CLINICAL CANCER RESEARCH (2011)
BCG-induced lupus vulgaris complicated by squamous cell carcinoma in a 7-year-old child
Binod Kumar Thakur et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2011)
Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells
Gerty Schreibelt et al.
BLOOD (2010)
Effect of BCG stimulus on proinflammatory cytokine production in laryngeal cancer
Luiz Carlos Conti-Freitas et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
MEASLES VIRUS: EVIDENCE FOR ASSOCIATION WITH LUNG CANCER
Netta Sion-Vardy et al.
EXPERIMENTAL LUNG RESEARCH (2009)
Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection
Sven-Eric Olsson et al.
HUMAN VACCINES (2009)
Basal cell carcinoma in a bacillus Calmette - Guerin scar
Mualla Polat et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2009)
Does yellow fever 17D vaccine protect against melanoma?
G. Mastrangelo et al.
VACCINE (2009)
Risk of lymphoma and leukaemia after bacille Calmette-Guerin and smallpox vaccination: A Danish case-cohort study
Marie Villumsen et al.
VACCINE (2009)
Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancer
Howard L. Kaufman et al.
CLINICAL CANCER RESEARCH (2008)
Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus
Jian Qiao et al.
CLINICAL CANCER RESEARCH (2008)
Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival - A report from the Children's Oncology Group
Paul A. Meyers et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses
Denis Gaucher et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
A new strategy to induce effective antitumour response in vitro and in vivo
M. Wang et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
Immunotherapy with irradiated autologous leukemic cells in patients with B-CLL in early stages
Iwona Hus et al.
ONCOLOGY REPORTS (2008)
Increase of CD4+CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma:: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+CD25+ T lymphocytes
S. Audia et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Evaluation of a novel immunomodulator composed of human chorionic gonadotropin and bacillus Calmette-Guerin for treatment of canine mast cell tumors in clinically affected dogs
Carolyn J. Henry et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2007)
Potent CTL induction by a whole cell pertussis vaccine in anti-tumor peptide immunotherapy
Arisa Yano et al.
MICROBIOLOGY AND IMMUNOLOGY (2007)
A phase I study of an allogeneic cell vaccine (VACCIMEL) with GM-CSF in melanoma patients
Maria M. Barrio et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Oncolytic measles virus targets high CD46 expression on multiple myeloma cells
Hooi Tin Ong et al.
EXPERIMENTAL HEMATOLOGY (2006)
Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin
MR Karagas et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity
T Querec et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Lung Cancer Immunotherapy
Luis E. Raez et al.
CLINICAL MEDICINE & RESEARCH (2005)
Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells
L Heinzerling et al.
BLOOD (2005)
Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-0897113; Silva Study)
G Giaccone et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer
R Myers et al.
CANCER GENE THERAPY (2005)
Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits
CA Uyl-de Groot et al.
VACCINE (2005)
Measles as a potential oncolytic virus
AK Fielding
REVIEWS IN MEDICAL VIROLOGY (2005)
Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients
KF Kolmel et al.
EUROPEAN JOURNAL OF CANCER (2005)
Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control
B Krone et al.
EUROPEAN JOURNAL OF CANCER (2005)
Periocular sarcoid in a horse
AM Komáromy et al.
VETERINARY OPHTHALMOLOGY (2004)
Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01
RE Smith et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus
BD Anderson et al.
CANCER RESEARCH (2004)
Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside
PB Chapman et al.
CLINICAL CANCER RESEARCH (2004)
Age-dependent differences in the efficacy of cancer immunotherapy in C57BL and AKR mouse strains
T Kaptzan et al.
EXPERIMENTAL GERONTOLOGY (2004)
Oncolytic measles viruses for cancer therapy
T Nakamura et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Identification of tumor-specific antibodies in patients with breast cancer vaccinated with gene-modified allogeneic tumor cells
A Dols et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Generation of vaccine-primed lymphocytes for the treatment of head and neck cancer
AE Chang et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2003)
Adjuvant immunotherapy of patients with high-risk melanoma using vaccinia viral lysates of melanoma: Results of a randomized trial
P Hersey et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox:: Results of the FEBIM study
A Pfahlberg et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
A phase II study of active specific immunotherapy and 5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma
A Baars et al.
BRITISH JOURNAL OF CANCER (2002)
Evaluation of excision, cryosurgery and local BCG vaccination for the treatment of equine sarcoids
A Martens et al.
VETERINARY RECORD (2001)
Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice
D Grote et al.
BLOOD (2001)
CancerVax, an allogeneic tumor cell vaccine, induces specific humoral and cellular immune responses in advanced colon cancer
N Habal et al.
ANNALS OF SURGICAL ONCOLOGY (2001)
Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis
M Boirivant et al.
JOURNAL OF IMMUNOLOGY (2001)
Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule
H Hörig et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2000)
Immunological effects of BCG as an adjuvant in autologous tumor vaccines
Q Li et al.
CLINICAL IMMUNOLOGY (2000)
Observed localization of the long-term cultured rat adherent natural killer cells in mammary tumor tissues
SZ Gu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2000)